Company Search:
Advanced Search
Sponsored Links
Syngen Biotech Co Ltd Company Snapshot
Syngen Biotech Co Ltd operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Syngen Biotech Co Ltd with three other companies in this sector in TAIWAN : Chunghwa Chemical Synthesis & Biotech Co Ltd (2019 sales of 1.16 billion Taiwanese Dollars [US$40.22 million] of which 54% was Taiwan), Savior Lifetec Corp (1.32 billion Taiwanese Dollars [US$45.85 million] of which 100% was Drugs Development, Production and Sales), and Panion & Bf Biotech Inc. (1.57 billion Taiwanese Dollars [US$54.73 million] of which 77% was Taiwan).

Sales Analysis. Syngen Biotech Co Ltd reported sales of 1.30 billion Taiwanese Dollars (US$45.11 million) for the year ending December of 2019. This represents an increase of 20.1% versus 2018, when the company's sales were 1.08 billion Taiwanese Dollars . Sales at Syngen Biotech Co Ltd have increased during each of the previous five years (and since 2014, sales have increased a total of 133%). Sales of Functional Food and Mupirocin saw an increase of 20.3% in 2019, from 1.07 billion Taiwanese Dollars to 1.29 billion Taiwanese Dollars . Not all segments of Syngen Biotech Co Ltd experienced an increase in sales in 2019: sales of Other fell 3.3% to 9.10 million Taiwanese Dollars . (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Syngen Biotech Co Ltd
  Stock Performance Chart for Syngen Biotech Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/16/2020): 109.50
(Figures in Taiwanese Dollars )
1 Week -4.8%   13 Weeks -2.7%  
4 Weeks -6.4%   52 Weeks -13.1%  
Syngen Biotech Co Ltd Key Data:
  Ticker: 8279 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 1,297,269,000
(Year Ending Jan 2020).
Employees: 212
  Currency: Taiwanese Dollars Market Cap: 2,967,559,500
  Fiscal Yr Ends: December Shares Outstanding: 27,101,000
  Share Type: Gu Closely Held Shares: 17,717,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.